Brand family
Micardis HCT
Hydrochlorothiazide and Telmisartan · Boehringer Ingelheim Pharmaceuticals
United States
- Presentations
- 3
- Markets
- 1
Micardis HCT is a brand of Hydrochlorothiazide and Telmisartan marketed by Boehringer Ingelheim Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Hydrochlorothiazide and Telmisartan
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 12.5 mg/40 mg tablet, 12.5 mg/80 mg tablet, 25 mg/80 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Micardis HCT 12.5 mg/40 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Micardis HCT 12.5 mg/80 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Micardis HCT 25 mg/80 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Micardis HCT
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.